TY - JOUR
T1 - Face-to-face four hand technique in vestibular schwannoma surgery
T2 - results from 256 Danish patients with larger tumors
AU - Springborg, Jacob Bertram
AU - Lang, Jeppe Mathias
AU - Fugleholm, Kåre
AU - Poulsgaard, Lars
PY - 2020/1
Y1 - 2020/1
N2 - BACKGROUND: The objective of this study was to investigate the clinical outcome after microsurgical treatment of vestibular schwannomas using face-to-face four hand technique in 256 Danish patients treated in the Department of Neurosurgery at the Copenhagen University Hospital from 2009 to 2018.METHODS: Data were retrospectively collected from patient records.RESULTS: The mean tumor size was 30.6 mm and approximately 46% of the patients had tumors >30 mm. In around 1/3 of the patients a retrosigmoid approach was used and in 2/3 a translabyrinthine. In 50% of the patients, the tumor was completely removed, and in 38%, only smaller remnants were left to preserve facial function. The median operative time was approximately 2.5 h for retrosigmoid approach, and for translabyrinthine approach, it was around 3.5 h. One year after surgery, 84% of the patients had a good facial nerve function (House-Brackmann grade 1-2). In tumors ≤ 30 mm approximately 89% preserved good facial function, whereas this was only the case for around 78% of the patients with tumors > 30 mm. In 60% of the patients who had poor facial nerve function at hospital discharge, the function improved to good facial function within the 1 year follow-up period. Four patients died within 30 days after surgery, and 6% underwent reoperation for cerebrospinal fluid leakage.CONCLUSION: Surgery for vestibular schwannomas using face-to-face four hand technique may reduce operative time and can be performed with lower risk and excellent facial nerve outcome. The risk of surgery increases with increasing tumor size.
AB - BACKGROUND: The objective of this study was to investigate the clinical outcome after microsurgical treatment of vestibular schwannomas using face-to-face four hand technique in 256 Danish patients treated in the Department of Neurosurgery at the Copenhagen University Hospital from 2009 to 2018.METHODS: Data were retrospectively collected from patient records.RESULTS: The mean tumor size was 30.6 mm and approximately 46% of the patients had tumors >30 mm. In around 1/3 of the patients a retrosigmoid approach was used and in 2/3 a translabyrinthine. In 50% of the patients, the tumor was completely removed, and in 38%, only smaller remnants were left to preserve facial function. The median operative time was approximately 2.5 h for retrosigmoid approach, and for translabyrinthine approach, it was around 3.5 h. One year after surgery, 84% of the patients had a good facial nerve function (House-Brackmann grade 1-2). In tumors ≤ 30 mm approximately 89% preserved good facial function, whereas this was only the case for around 78% of the patients with tumors > 30 mm. In 60% of the patients who had poor facial nerve function at hospital discharge, the function improved to good facial function within the 1 year follow-up period. Four patients died within 30 days after surgery, and 6% underwent reoperation for cerebrospinal fluid leakage.CONCLUSION: Surgery for vestibular schwannomas using face-to-face four hand technique may reduce operative time and can be performed with lower risk and excellent facial nerve outcome. The risk of surgery increases with increasing tumor size.
KW - Adult
KW - Aged
KW - Cerebrospinal Fluid Leak/epidemiology
KW - Facial Nerve/surgery
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Neuroma, Acoustic/pathology
KW - Neurosurgical Procedures/adverse effects
KW - Postoperative Complications/epidemiology
KW - Reoperation/statistics & numerical data
KW - Treatment outcome
KW - Microsurgery
KW - Vestibular schwannoma
UR - http://www.scopus.com/inward/record.url?scp=85075569036&partnerID=8YFLogxK
U2 - 10.1007/s00701-019-04148-0
DO - 10.1007/s00701-019-04148-0
M3 - Journal article
C2 - 31768756
VL - 162
SP - 61
EP - 69
JO - Acta Neurochirurgica
JF - Acta Neurochirurgica
SN - 0001-6268
IS - 1
ER -